Sequencing of Sipuleucel-T and Androgen Deprivation Therapy in Men With Hormone-Sensitive Biochemically Recurrent Prostate Cancer: A Phase II Randomized Trial

Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-16-1780
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

Improving Bone Health in Men With Prostate Cancer Receiving Androgen Deprivation Therapy: Results of a Randomized Phase 2 Trial

Cancer
Cancer ResearchOncology
2017English

Eastern Cooperative Oncology Group Phase II Trial of Lapatinib in Men With Biochemically Relapsed, Androgen Dependent Prostate Cancer

Urologic Oncology: Seminars and Original Investigations
OncologyUrology
2013English

Phase II Trial of Acai Juice Product in Biochemically Recurrent Prostate Cancer

Integrative Cancer Therapies
OncologyAlternative MedicineComplementary
2018English

A Randomized Phase II Trial Evaluating Different Schedules of Zoledronic Acid on Bone Mineral Density in Patients With Prostate Cancer Beginning Androgen Deprivation Therapy

Clinical Genitourinary Cancer
OncologyUrology
2013English

Psychological Distress in Men With Prostate Cancer Receiving Adjuvant Androgen-Deprivation Therapy

Urologic Oncology: Seminars and Original Investigations
OncologyUrology
2013English

Quality of Life Decrements in Men With Prostate Cancer Undergoing Androgen Deprivation Therapy

Clinical Endocrinology
EndocrinologyMetabolismDiabetes
2016English

Screening for Androgen Deprivation Therapy Related Side Effects in Men With Prostate Cancer

English

Association Between Androgen Deprivation Therapy Use and Diagnosis of Dementia in Men With Prostate Cancer

JAMA network open
Medicine
2019English

Androgen Deprivation Therapy for Prostate Cancer

2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy